BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6289340)

  • 1. Programming of rat hepatic arylhydrocarbon hydroxylase activity during late neonatal period.
    Simpson VJ; Chung LW
    Proc West Pharmacol Soc; 1982; 25():257-61. PubMed ID: 6289340
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of inducers and inhibitors of mixed-function oxidasts on benzo(a)pyrene binding to the DNA of rat liver nuclei.
    Alexandrov K; Thompson MH
    Cancer Res; 1977 May; 37(5):1443-9. PubMed ID: 856463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the binding of the carcinogen benzo(a)pyrene to rat liver DNA in vivo by selective induction of microsomal and nuclear aryl hydrocarbon hydroxylase activity.
    Viviani A; Lutz WK
    Cancer Res; 1978 Dec; 38(12):4640-4. PubMed ID: 719642
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of vitamin A deficiency on pulmonary and hepatic in vitro metabolism of benzo(a)pyrene in rat.
    Dogra SC; Khanduja KL; Sharma RR; Hom T; Varanasi U
    Biochem Int; 1985 Dec; 11(6):869-84. PubMed ID: 3937530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance of benzo(a)pyrene by isolated rat liver and lung: alterations in perfusion and metabolic capacity.
    Wiersma DA; Roth RA
    J Pharmacol Exp Ther; 1983 Apr; 225(1):121-5. PubMed ID: 6300370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of tamoxifen inhibition of aryl hydrocarbon hydroxylase activity of intestinal and hepatic microsomes from male rats.
    Al-Turk WA; Stohs SJ
    Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):69-76. PubMed ID: 6302754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical study on the contributions of two molecular species of microsomal cytochrome P-450 to the metabolism of benzo(a)pyrene by rat liver microsomes.
    Hara E; Kawajiri K; Tagashira Y
    Cancer Res; 1983 Aug; 43(8):3604-8. PubMed ID: 6305488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsome-dependent binding of benzo(alpha)pyrene and aflatoxin B1 to DNA, and benzo(alpha)pyrene binding to aflatoxin-conjugated DNA.
    Alexandrov K; Frayssinet C
    Cancer Res; 1974 Dec; 34(12):3289-95. PubMed ID: 4154143
    [No Abstract]   [Full Text] [Related]  

  • 9. The benzo(alpha)pyrene deoxyribonucleoside products isolated from DNA after metabolism of benzo(alpha)pyrene by rat liver microsomes in the presence of DNA.
    King HW; Thompson MH; Brookes P
    Cancer Res; 1975 May; 35(5):1263-9. PubMed ID: 1120312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction and modification of rat liver microsomal arylamide N-hydroxylase by various pretreatments.
    Razzouk C; Batardy-Grégoire M; Roberfroid M
    Mol Pharmacol; 1982 Mar; 21(2):449-57. PubMed ID: 7099145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of caffeine on the hepatic microsomal mixed function oxidase system during phenobarbital and benzo[a]pyrene treatment in rats.
    Govindwar SP; Kachole MS; Pawar SS
    Toxicol Lett; 1988 Aug; 42(2):109-15. PubMed ID: 3406955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of microsomes and nuclear envelope in the metabolic activation of benzo(a)pyrene leading to binding with nuclear macromolecules.
    Pezzuto JM; Lea MA; Yang CS
    Cancer Res; 1977 Sep; 37(9):3427-33. PubMed ID: 884686
    [No Abstract]   [Full Text] [Related]  

  • 13. Benzo[a]pyrene metabolism in marine fish and some analytical aspects of its metabolites.
    Schoor WP
    Natl Cancer Inst Monogr; 1984 May; 65():391-6. PubMed ID: 6087146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose dependent activation of rat small intestinal monooxygenase-activity towards benzo(a)pyrene and 7-ethoxycoumarin after oral pretreatment with cimetidine.
    Borm PJ; Kroon M; Noordhoek J; Platt KL; Oesch F
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):99-111. PubMed ID: 6328602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermis: a site of drug metabolism in neonatal rat skin. Studies on cytochrome P-450 content and mixed-function oxidase and epoxide hydrolase activity.
    Bickers DR; Dutta-Choudhury T; Mukhtar H
    Mol Pharmacol; 1982 Jan; 21(1):239-47. PubMed ID: 7132961
    [No Abstract]   [Full Text] [Related]  

  • 16. Diphenylhydantoin effect on neonatal and adult rat hepatic drug metabolism.
    Eling TE; Harbison RD; Becker BA; Fouts JR
    J Pharmacol Exp Ther; 1970 Jan; 171(1):127-34. PubMed ID: 5410930
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of trace elements on the hydroxylation of benzo(a)pyrene].
    Calop J; Burckhart MF; Fontanges R
    Eur J Toxicol Environ Hyg; 1976; 9(5):271-86. PubMed ID: 1009996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of aflatoxin B1 on the hepatic microsomal mixed function oxidase system during phenobarbital and benzo(a)pyrene treatment in chickens.
    Govindwar SP; Adav SS
    Vet Hum Toxicol; 1999 Aug; 41(4):210-2. PubMed ID: 10434373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzo(a)pyrene phenol production by perfused rat liver and its inhibition by ethanol.
    Reinke LA; McManus P; Kauffman FC; Thurman RG
    Cancer Res; 1982 May; 42(5):1681-5. PubMed ID: 6279282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic determinants of benzo[a]pyrene metabolism to dihydrodiol epoxides by 3-methylcholanthrene-induced rat liver microsomes.
    Keller GM; Turner CR; Jefcoate CR
    Mol Pharmacol; 1982 Sep; 22(2):451-8. PubMed ID: 6292697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.